Literature DB >> 15814340

Trisomy 22 as the sole karyotypic abnormality in myelodysplastic syndrome.

Tohru Takahashi, Sayaka Harada, Mariko Oki, Mitsuru Yoshimoto, Masayuki Tsujisaki.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15814340     DOI: 10.1532/IJH97.04169

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.

Authors:  I Kitabayashi; Y Aikawa; A Yokoyama; F Hosoda; M Nagai; N Kakazu; T Abe; M Ohki
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

2.  Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16.

Authors:  K F Wong; Y L Kwong
Journal:  Cancer Genet Cytogenet       Date:  1999-03

3.  Trisomy 22: a subclone marker?

Authors:  Ronald Feitosa Pinheiro; Maria de Lourdes Lopes Ferrari Chauffaille; Perla Vicari; Celso Arrais Rodrigues; Luis Arthur Flores Pelloso; José Orlando Bordin; Mihoko Yamamoto
Journal:  Cancer Genet Cytogenet       Date:  2003-05

4.  A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.

Authors:  S E Langabeer; D Grimwade; H Walker; J R Rogers; A K Burnett; A H Goldstone; D C Linch
Journal:  Br J Haematol       Date:  1998-05       Impact factor: 6.998

5.  Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13).

Authors:  K Ida; I Kitabayashi; T Taki; M Taniwaki; K Noro; M Yamamoto; M Ohki; Y Hayashi
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

6.  Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation.

Authors:  M Eder; K Battmer; S Kafert; A Stucki; A Ganser; B Hertenstein
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

7.  Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

Authors:  E Mensink; A van de Locht; A Schattenberg; E Linders; N Schaap; A Geurts van Kessel; T De Witte
Journal:  Br J Haematol       Date:  1998-08       Impact factor: 6.998

8.  Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).

Authors:  G Gradl; H Tesch; G Schwieder; T Wagner; C Fonatsch
Journal:  Blut       Date:  1989-06

9.  Trisomy 22--a new abnormality found in acute leukemia characterized by eosinophilia and monocytoid blasts expressing immature differentiation antigens.

Authors:  V Najfeld; S Seremetis; K Troy; J Uehlinger; P Schwartz; J Cuttner
Journal:  Cancer Genet Cytogenet       Date:  1986-10

10.  Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16?

Authors:  N Grois; H Nowotny; E Tyl; O Krieger; P Kier; O A Haas
Journal:  Cancer Genet Cytogenet       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.